From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
Line 26: Line 26:
#Jeffs-2010 pmid=21411755
#Jeffs-2009 pmid=20041153
#Jeffs-2009 pmid=20041153
#Jenkins-2008 pmid=19079258
#Jenkins-2008 pmid=19079258

Revision as of 20:48, 13 June 2011

Aaron Jeffs

Department of Pathology
Dunedin School of Medicine
University of Otago
New Zealand

aaron.jeffs at


Research Interests

  • Cancer genetics
  • Oncogenomics


  • PhD (Otago) 2001.
  • MSc Hons (Canterbury) 1994.



  1. Slatter TL, Hung N, Campbell H, Rubio C, Mehta R, Renshaw P, Williams G, Wilson M, Engelmann A, Jeffs A, Royds JA, Baird MA, and Braithwaite AW. . pmid:21411755. PubMed HubMed [Jeffs-2010]
  2. Jeffs AR, Glover AC, Slobbe LJ, Wang L, He S, Hazlett JA, Awasthi A, Woolley AG, Marshall ES, Joseph WR, Print CG, Baguley BC, and Eccles MR. . pmid:20041153. PubMed HubMed [Jeffs-2009]
  3. Jenkins ZA, van Kogelenberg M, Morgan T, Jeffs A, Fukuzawa R, Pearl E, Thaller C, Hing AV, Porteous ME, Garcia-Miñaur S, Bohring A, Lacombe D, Stewart F, Fiskerstrand T, Bindoff L, Berland S, Adès LC, Tchan M, David A, Wilson LC, Hennekam RC, Donnai D, Mansour S, Cormier-Daire V, and Robertson SP. . pmid:19079258. PubMed HubMed [Jenkins-2008]
  4. Dziarmaga A, Hueber PA, Iglesias D, Hache N, Jeffs A, Gendron N, Mackenzie A, Eccles M, and Goodyer P. . pmid:16735463. PubMed HubMed [Dziarmaga-2006]
  5. M. Futschik, A.Jeffs, S.Pattison, N.Kasabov, M.Sullivan, A.Merrie, A.Reeve (2002). Gene expression profiling of metastatic and non-metastatic colorectal cancer cell-lines. Genome Letters 1(1):26-34. [Futschik-2002]
  6. Jeffs AR, Wells E, and Morris CM. . pmid:11550282. PubMed HubMed [Jeffs-2001]
  7. Benjes SM, Millow LJ, Jeffs AR, Sowerby SJ, Reeve AE, and Morris CM. . pmid:10534772. PubMed HubMed [Benjes-1999]
  8. Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, and Morris CM. . pmid:9536079. PubMed HubMed [Jeffs-1998]
  9. Morris C, Jeffs A, Smith T, McDonald M, Board P, Kennedy M, and Fitzgerald P. . pmid:8637725. PubMed HubMed [Morris-1996]
All Medline abstracts: PubMed HubMed


  1. Robson, Ewan, Jeffs, Aaron, and Eccles, Michael. Off-target response to decoy oligodeoxynucleotide treatment. Available from Nature Precedings (2008) [Robson-2008]



  • "p53 isoforms, miRNA, cancer", Dunedin School of Medicine Dean's Bequest Round, 27 May 2011 for 1 year ($14,569). A. Jeffs and A. Braithwaite.


  • "MicroRNA function in melanoma", The Healthcare Otago Charitable Trust, October 2010 for 1 year ($14,127). A. Jeffs.
  • "Urinary microRNA: a novel marker of acute kidney injury", University of Otago Research grant, October 2010 for 1 year ($44,000). R. Walker (PI), A. Jeffs, Z. Endre, and J. Pickering.
  • "Can isoforms of the p53 tumour suppressor cause cancer?", Health Research Council of New Zealand, June 2010 for 36 months ($1,158,492). A. Braithwaite (PI), N. Hung, A. Jeffs, and T. Slatter.
  • "A novel gene that modifies melanoma invasive potential", Dunedin School of Medicine Dean's Bequest Fund, June 2010 for 1 year ($5420). A. Jeffs.
  • "Grant-in-aid for QMB Cancer meeting 2010", Maurice & Phyllis Paykel Trust ($4000). A. Jeffs & M. Eccles.
  • Professional Development Award to attend the AMATA10 meeting, Hobart, Australia, Genesis Oncology Trust ($1,957). A. Jeffs.
  • Dunedin School of Medicine Travel Grant to attend the AMATA10 meeting, Hobart, Australia ($885). A.Jeffs.


  • "Genome instability in melanoma", NZ Lottery Grants Board (Application 278243), 01/01/2010 for 2 years ($116,328). A. Jeffs (PI), M. Eccles, and B. Baguley.
  • "The molecular basis of melanoma: integrating microRNA expression and DNA copy number variation to define clinically relevant markers of invasion and prognosis", The HealthCare Otago Charitable Trust ($10,434), 01/02/10 for 1 year. A. Jeffs.

Personal tools